Compare Stocks: CVN, SQZ, SEPL, GENL, and OPHR

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
SQZ SQZ Biotechnologies	$0.05	$0.05	$0.25 ▼ $3.56	$1.37M	2.34	455,220 shs	27,726 shs

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
SQZ SQZ Biotechnologies	-3.63%	-7.00%	-1.06%	+29.53%	-99.31%

Bitcoin Rockets To Record High But Buy THIS Instead (Ad)

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
SQZ SQZ Biotechnologies	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
SQZ SQZ Biotechnologies	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
SQZ SQZ Biotechnologies	$18.16M	0.08	N/A	N/A	$1.94 per share	0.02

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
SQZ SQZ Biotechnologies	-$79.46M	-$2.61	N/A	N/A	N/A	-369.96%	-119.83%	-59.90%	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
SQZ SQZ Biotechnologies	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
SQZ SQZ Biotechnologies	N/A	3.50	3.50

Ownership

Institutional Ownership

Company	Institutional Ownership
SQZ SQZ Biotechnologies	38.51%

Insider Ownership

Company	Insider Ownership
SQZ SQZ Biotechnologies	16.00%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
SQZ SQZ Biotechnologies	53	29.49 million	24.77 million	Not Optionable

CVN, SQZ, SEPL, GENL, and OPHR Headlines

Source	Headline
	Reviewing BioAtla (NASDAQ:BCAB) and SQZ Biotechnologies (NYSE:SQZ) americanbankingnews.com - April 22 at 1:26 AM
	VC funding update: who raised money in March? bizjournals.com - April 1 at 11:06 AM
	SQZ, Portal founder Armon Sharei on starting over in biotech biopharmadive.com - March 26 at 10:35 AM
	Portal Biotechnologies Announces $5M Pre-Seed Round Led By Pear VC finance.yahoo.com - March 19 at 10:20 AM
	SQZ, months after 80% layoffs, opts for liquidation and $11.8M asset fire sale to Stemcell fiercebiotech.com - March 1 at 10:56 AM
	Rx Rundown: Gilead Sciences, Latigo Biotherapeutics, Exscientia and more mmm-online.com - February 16 at 8:05 AM
	SQZB SQZ Biotechnologies Company seekingalpha.com - December 28 at 1:42 PM
	SQZ Biotechnologies Co Ordinary Shares SQZB morningstar.com - December 12 at 8:37 PM
	SQZ founder Armon Sharei opens Portal to to simplify intracellular delivery fiercebiotech.com - December 12 at 10:35 AM
	'Medicine at a bigger scale': FUJIFILM Diosynth Biotechnologies unveils new Holly Springs drug manufacturing site wral.com - November 11 at 8:41 PM
	‘Difficult but necessary steps’: SQZ lays off 80% of staff, RegenXBio cuts 15% fiercebiotech.com - November 9 at 10:34 AM
	SQZ Biotechnologies Reports Third Quarter 2023 Financial Results and Recent Portfolio Updates finance.yahoo.com - November 8 at 6:33 PM
	SQZ Biotechnologies GAAP EPS of -$0.80 misses by $0.30, revenue of $0M msn.com - November 8 at 6:33 PM
	Lifeline Biotechnologies Inc LLBO morningstar.com - November 4 at 11:41 PM
	SQZ Biotechnologies Reports Data for Clinical Programs at the Society for Immunotherapy of Cancer Annual Meeting finance.yahoo.com - November 3 at 7:42 PM
	SQZ Biotechnologies Reports Second Quarter 2023 Financial Results and Recent Portfolio Updates finance.yahoo.com - August 10 at 9:16 PM
	Sqz Biotechnologies Co (SQZB) investing.com - August 3 at 7:45 AM
	Roche declines to take up option on SQZ Bio’s SQZ-APC-HPV program thepharmaletter.com - July 27 at 12:11 AM
	Roche Passes on Option to Advance Cell Therapy in HPV-Positive Tumors With SQZ Biotechnologies precisionmedicineonline.com - July 25 at 10:53 PM
	Roche Decides Not to Exercise Solid Tumor Option with SQZ biospace.com - July 25 at 10:53 PM
	SQZ Biotechnologies Provides Update on Collaboration with Roche benzinga.com - July 25 at 12:37 PM
	Roche snubs SQZ HPV 16 programme, leaving the beleaguered company in the lurch pharmaceutical-technology.com - July 25 at 12:37 PM
	Understanding the Risks of Investing in SQZ Biotechnologies Company (SQZ) knoxdaily.com - July 5 at 1:10 PM
	SQZ Biotechnologies to be delisted from the NYSE seekingalpha.com - July 3 at 11:23 PM

Media Sentiment Over Time

Company Descriptions

SQZ Biotechnologies

NYSE:SQZ

SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.

Compare Stocks